Literature DB >> 25900252

Functional histopathology of keloid disease.

N Jumper1, R Paus2, A Bayat3.   

Abstract

Keloid disease is a benign, yet locally aggressive and recurrent cutaneous fibroproliferative condition characterised by excessive scarring. Unique to humans, keloids represent the end-point of a spectrum of abnormal wound healing, are aesthetically disfiguring and can cause major functional impairment. Its heterogeneous phenotype can confound clinical diagnosis leading to mismanagement. This review examines the histological morphology of keloid disease relative to the underlying pathobiology, places it in the context of other cutaneous fibroses and highlights gaps within the literature that hinder differential diagnosis. The pathological similarity to hypertrophic scarring, dermatofibrosarcoma protuberans, dermatofibroma and scleroderma emphasise the importance of detailing the architectural and cellular components of this unique entity. In the papillary dermis keloid tumours show a tongue-like advancing edge that resembles invasive tumour growth. A thickened but flattened epidermis, hyalinised haphazardly arranged collagen bundles that dominate the dermis with subsequent obliteration of the papillary-reticular boundary along with displacement and eventually destruction of skin appendages, exemplify additional hallmark findings associated with keloid disease. Compared to healthy skin, keloid scars show an increased type I/III collagen ratio, decreased fibrillin-1 and decorin expression, increased dermal cellularity and increased expression of fibronectin, versican, elastin and tenascin in the reticular dermis and hyaluronan and osteopontin in the epidermis. We illustrate these "pathognomonic" features of keloid disease by representative micrographs and discuss them in the context of inflammation, hypoxia and tension--as key elements of keloid disease. Finally, we highlight deficits within the keloid research literature as well as discuss important areas for future research in keloid histology.

Entities:  

Mesh:

Year:  2015        PMID: 25900252     DOI: 10.14670/HH-11-624

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  35 in total

1.  Novel insights into a reputably irreversible process: combined mRNA and miRNA profiling of tissue from vesicourethral anastomotic stenosis after radical prostatectomy.

Authors:  T S Worst; K Daskalova; A Steidler; K Berner-Leischner; R Röth; B Niesler; C-A Weis; M C Kriegmair; P Erben; D Pfalzgraf
Journal:  World J Urol       Date:  2017-06-20       Impact factor: 4.226

Review 2.  Linking Race, Cancer Outcomes, and Tissue Repair.

Authors:  Jung S Byun; Samson Park; Ambar Caban; Alana Jones; Kevin Gardner
Journal:  Am J Pathol       Date:  2017-11-11       Impact factor: 4.307

3.  Regulation of Langerhans cell functions in a hypoxic environment.

Authors:  Daniele Pierobon; Federica Raggi; Irene Cambieri; Simone Pelassa; Sergio Occhipinti; Paola Cappello; Francesco Novelli; Tiziana Musso; Alessandra Eva; Carlotta Castagnoli; Luigi Varesio; Mirella Giovarelli; Maria Carla Bosco
Journal:  J Mol Med (Berl)       Date:  2016-03-10       Impact factor: 4.599

4.  STAT3 signalling pathway is implicated in keloid pathogenesis by preliminary transcriptome and open chromatin analyses.

Authors:  Yun-Shain Lee; Ya-Chen Liang; Ping Wu; David A Kulber; Kylie Tanabe; Cheng-Ming Chuong; Randall Widelitz; Tai-Lan Tuan
Journal:  Exp Dermatol       Date:  2019-04       Impact factor: 3.960

5.  Wound natural healing in treatment of tumor-like hypertrophic scar.

Authors:  Tong Han; De-Feng Lin; Hua Jiang
Journal:  An Bras Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.896

Review 6.  Purinergic signaling in scarring.

Authors:  Davide Ferrari; Roberto Gambari; Marco Idzko; Tobias Müller; Cristina Albanesi; Saveria Pastore; Gaetano La Manna; Simon C Robson; Bruce Cronstein
Journal:  FASEB J       Date:  2015-09-02       Impact factor: 5.191

7.  Co-localization of LTBP-2 with FGF-2 in fibrotic human keloid and hypertrophic scar.

Authors:  Mohamed A Sideek; Abdulrahman Teia; Zlatko Kopecki; Allison J Cowin; Mark A Gibson
Journal:  J Mol Histol       Date:  2015-12-07       Impact factor: 2.611

Review 8.  Fibroblast heterogeneity: implications for human disease.

Authors:  Magnus D Lynch; Fiona M Watt
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

9.  Pirfenidone inhibits epithelial-mesenchymal transition in keloid keratinocytes.

Authors:  Latha Satish; Alexander Evdokiou; Eleni Geletu; Jennifer M Hahn; Dorothy M Supp
Journal:  Burns Trauma       Date:  2020-02-27

10.  Multiple Cytokines Elevated in Patients with Keloids: Is It an Indication of Auto-Inflammatory Disease?

Authors:  Ferdinand W Nangole; Kelsey Ouyang; Omu Anzala; Julius Ogengo; George W Agak
Journal:  J Inflamm Res       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.